Key Highlights
- Lumentum reached a fresh 52-week peak of $1,072.70 on Monday following Citic Securities’ price target increase from $620 to $1,186.
- The company will enter the Nasdaq-100 index on May 18, taking CoStar Group’s (CSGP) spot, triggering a 4.8% intraday rally.
- Several Wall Street firms raised their price objectives, with Rosenblatt at $1,300, Raymond James at $1,014, and TD Cowen at $995, bringing the analyst consensus to $1,012.43.
- Third-quarter results delivered $2.37 in earnings per share, surpassing the $2.27 forecast, while revenue jumped 90.1% year-over-year to $808.4 million.
- Institutional holders control 94.05% of shares, with significant new stakes from Norges Bank and Value Aligned Research Advisors during the fourth quarter.
Lumentum (LITE) shares climbed to a new 52-week peak on Monday, reaching $1,072.70 during intraday trading after a substantial analyst price target revision and confirmation of its Nasdaq-100 addition pushed the stock significantly higher from its previous close of $903.80.
Citic Securities led the analyst activity, raising its price objective from $620 to $1,186 — representing more than a 90% upward revision. This adjustment arrived alongside multiple other target increases announced last Wednesday.
Rosenblatt elevated its target to $1,300 while maintaining a buy recommendation. Raymond James affirmed its outperform stance with a $1,014 objective. TD Cowen adjusted upward to $995, Barclays moved to $1,000, and UBS lifted its neutral-rated target to $960. Among 20 covering analysts, the consensus rating now stands at Moderate Buy with an average price objective of $1,012.43.
The Nasdaq-100 addition provided additional momentum. Nasdaq announced Friday that Lumentum would take CoStar Group’s (CSGP) place in the index ahead of trading on May 18. Such announcements typically generate automatic purchases from passive funds and index-tracking vehicles required to replicate the index composition, with LITE responding through a 4.8% Monday advance.
Strong Quarterly Results Support Positive Outlook
The wave of analyst upgrades reflected solid fundamentals. Lumentum unveiled Q3 2026 results on May 5 showing $2.37 in earnings per share versus the $2.27 consensus forecast — a $0.10 outperformance. Revenue totaled $808.4 million, slightly below the $810.21 million projection, yet marking a 90.1% increase from the prior year. During the same quarter last year, the company generated just $0.57 per share.
For Q4 2026, Lumentum provided earnings guidance between $2.85 and $3.05 per share. Wall Street currently models full-year EPS at $5.95.
The company maintains an $82.78 billion market capitalization, a price-to-earnings ratio of 197.05, and a beta coefficient of 1.53. The 50-day moving average stands at $776.13, while the 200-day average reaches $502.93 — illustrating the stock’s rapid appreciation.
Major Investment Firms Expand Holdings
Institutional investment activity has surged dramatically. Arrowstreet Capital expanded its holdings by 8,579% during Q3, while Norges Bank established a fresh position valued at approximately $474.5 million in Q4. Value Aligned Research Advisors contributed around $432 million in new investments. Assenagon increased its stake by 707%. Institutional holders now control 94.05% of outstanding shares.
Company insiders have moved in the opposite direction. CFO Wajid Ali divested 5,302 shares in late February at $691.13 per share. Insider Yuen Wupen sold 3,157 shares in mid-February at $538. Over the past 90 days, insiders collectively sold 60,926 shares totaling approximately $36.25 million. Insider ownership currently represents just 0.43% of the company.
The stock closed Monday’s session at $1,061.43 with trading volume exceeding 5.7 million shares.
